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Abstract
The glomerular podocyte is a highly specialized and polarized kidney cell type that contains major processes and foot
processes that extend from the cell body. Foot processes from adjacent podocytes form interdigitations with those of
adjacent cells, thereby creating an essential intercellular junctional domain of the renal filtration barrier known as the slit
diaphragm. Interesting parallels have been drawn between the slit diaphragm and other sites of cell-cell contact by
polarized cells. Notably mutations in several genes encoding proteins localized to the foot processes can lead to proteinuria
and kidney failure. Mutations in the Wilm’s tumor gene (WT1) can also lead to kidney disease and one isoform of WT1,
WT1(+KTS), has been proposed to regulate gene expression post-transcriptionally. We originally sought to identify mRNAs
associated with WT1(+KTS) through an RNA immunoprecipitation and microarray approach, hypothesizing that the proteins
encoded by these mRNAs might be important for podocyte morphology and function. We identified a subset of mRNAs
that were remarkably enriched for transcripts encoding actin-binding proteins and other cytoskeletal proteins including
several that are localized at or near the slit diaphragm. Interestingly, these mRNAs included those of a-actinin-4 and non-
muscle myosin IIA that are mutated in genetic forms of kidney disease. However, isolation of the mRNAs occurred
independently of the expression of WT1, suggesting that the identified mRNAs were serendipitously co-purified on the basis
of co-association in a common subcellular fraction. Mass spectroscopy revealed that other components of the actin
cytoskeleton co-purified with these mRNAs, namely actin, tubulin, and elongation factor 1a. We propose that these mRNAs
encode a number of proteins that comprise a highly specialized protein interactome underlying the slit diaphragm.
Collectively, these gene products and their interactions may prove to be important for the structural integrity of the actin
cytoskeleton in podocytes as well as other polarized cell types.
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Introduction
The renal glomerulus is the site of plasma ultrafiltration and
disruption of glomerular function leads to progressive renal
insufficiency and end-stage renal disease (ESRD). The glomerular
filtration barrier is comprised of the fenestrated capillary
endothelium, the glomerular basement membrane (GBM), and
intercellular junctions between glomerular epithelial cells called
podocytes, which overlie the GBM [1,2]. The podocyte, a highly
specialized kidney cell type consists of a cell body, major processes,
and foot processes. The foot processes attach to the GBM and
form extensive interdigitations with foot processes of adjacent
podocytes to form a critical component of the filtration barrier
termed the slit diaphragm. The slit diaphragm consists of several
proteins that span the intercellular junctions with adjacent foot
processes which prevent the passage of large molecules. Impor-
tantly, disruption of podocyte function that disrupts the slit
diaphragm often leads to nephrotic syndrome and progressive
deterioration in renal function [1,2].
The complex structure of the podocyte is dependent upon a
highly structured cytoskeleton that is critical for the maintenance
of normal morphology and function. This highly dynamic network
is involved in meeting the ongoing mechanical demands of
filtration as well responses to cellular stress and injury [3–6].
Glomerular diseases that lead to proteinuria are associated with
foot process effacement, which involves alterations in the actin
cytoskeleton that retard normal slit diaphragm organization and
function [3–6]. Thus, proteins that are components of the actin
cytoskeleton, as well as proteins and pathways involved in its
regulation, are crucial for its function.
Mutations in genes encoding proteins involved in slit diaphragm
organization and actin cytoskeleton organization have been shown
to play important roles in the progression of glomerular disease.
Mutations in the gene encoding for nephrin, a transmembrane
adhesion protein, has been shown to be the cause of nephrotic
syndrome of the Finnish type [7]. In addition to nephrin, genetic
mutations in components of the slit diaphragm including podocin
(NPHS2), CD2-associated protein (CD2AP), and transient receptor
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inherited nephrotic syndromes leading to ESRD [8–11]. Notably,
TRPC6 has been shown to function in the regulation of calcium
influx at the slit diaphragm and increased TRPC channel activity
has been associated with reorganization of the actin cytoskeleton.
Given that mutations associated with inherited nephrotic syn-
drome are characterized by increased channel activity, TRPC6
activity can be functionally linked to cytoskeletal regulation and
maintenance [10,11].
The importance of the actin cytoskeleton in glomerular and
podocyte function is highlighted by mutations in a-actinin-4
(ACTN4), which leads to familial focal and segmental glomerulo-
sclerosis (FSGS) [12]. Mutations in non-muscle myosin IIa (Myh9),
lead to nephrotic syndrome in association with deafness, macro-
thrombocytopenia, and leukocyte inclusions in several syndromes
such as Fechtner and Epstein syndromes, which might collectively
be termed ‘‘Myh9 related diseases’’ [13–15]. The importance of
Myh9 in podocytes is further illustrated by two recent studies
which, using genome-wide association analysis through admixture
linkage disequilibrium, identified multiple Myh9 SNPs that were
associated with the increased risk of non-diabetic ESRD and
FSGS in African American populations [16,17].
In addition to the mutations described above, mutations in the
Wilm’s tumor gene (WT1) have also been associated with
glomerular disease. WT1 was originally identified as a gene
mutated in patients with Wilm’s nephroblastomas and mutations
in WT1 have been shown to be the cause of nephrotic syndrome.
WT1 mutations that lead to Denys-Drash syndrome and Frasier
syndrome are each associated with nephrotic syndrome, renal
failure, and intersex disorders, although only the former is
commonly associated with Wilm’s tumor [18]. Subsequent work
has also shown that WT1 is required for renal organogenesis and
the development of other organ systems [19–21]. WT1 encodes a
protein containing four zinc finger domains whose expression in
the mature kidney is limited to the podocyte. Alternative splicing
of the WT1 transcript results in the inclusion or skipping of 9
nucleotides in exon 9 that encode the amino acids Lysine-
Threonine-Serine (KTS) that are consequently present or absent
between the third and fourth zinc finger domains of the protein.
The protein isoform that does not contain the amino acids, WT1(-
KTS) has been abundantly shown to function as a transcription
factor. By contrast, the role of the more abundant protein isoform
containing these amino acids, WT1(+KTS) has been less well
defined, although it has been suggested that WT1(+KTS)
functions as an RBP involved in post-transcriptional gene
regulation [22,23]. Evidence that the WT1(+KTS) isoform has
important roles in podocyte function is provided by WT1
mutations in patients with Frasier syndrome cause a reduction in
relative levels of the WT1(+KTS) isoform. Similarly, mice with
complete absence of WT1(+KTS) develop abnormal podocyte
morphology and impaired foot process formation leading to renal
failure [24].
Immunoprecipitation of RNA binding proteins and identifica-
tion of the associated cellular RNAs by microarray analysis (often
called ‘‘RIP-CHIP’’) has been successfully used by a number of
groups (Reviewed in [25]). To investigate the potential post-
transcriptional regulatory functions of WT1(+KTS) we developed
a variation to the RIP-CHIP protocol. We sought to identify a
subset of WT1(+KTS)-associated mRNAs in podocytes that might
be physiologically important for glomerular function. In order to
identify potential candidate mRNAs associating with WT1(+KTS),
WT1(+KTS) was purified from cell extracts from a podocyte cell
line stably expressing an epitope tagged WT1(+KTS) construct.
DNA microarrays were then used to identify candidate target
mRNAs. An underlying hypothesis was that the proteins encoded
by mRNAs bound by WT1(+KTS) might define a ‘‘post-
transcriptional operon’’ that is important for maintenance of
podocyte morphology and function [26]. According to this
hypothesis, RBPs with important cellular functions co-regulate
the expression of gene transcripts that function in common
biochemical pathways or are present in common macromolecular
structures. The mRNAs that were co-purified in this study
demonstrated a remarkable enrichment for transcripts encoding
components of a protein-protein interaction network that
comprises the actin cytoskeleton. However, these mRNAs were
subsequently, and unexpectedly, shown not to be bound by
WT1(+KTS). However, while our findings did not address the
original hypothesis that WT1(+KTS) directly binds mRNAs in vivo,
we nonetheless identified transcripts that encode a subset of
interrelated, physiologically relevant proteins that we propose will
provide further insights into actin cytoskeletal organization.
Results
A modified RIP-CHIP approach used to identify
functionally relevant mRNAs
To investigate the potential post-transcriptional role and target
transcripts of WT1(+KTS) in podocytes, we developed a modified
RIP-CHIP approach using an expression construct originally
developed for a tandem affinity purification (TAP) protocol [27].
This expression construct contains a tag (‘‘FF-ZZ’’) consisting of
two copies of a C-terminal FLAG tags (‘‘FF’’) separated from two
more C-terminal IgG binding domains (‘‘ZZ’’) of protein A by a
cleavage site for the site specific tobacco etch virus (TEV) protease
(Figure 1A) [27,28].
In order to identify gene transcripts encoding podocyte-relevant
products, we made use of the conditionally immortalized mouse
MPC-5 podocyte cell line [29]. MPC-5 cells were established with
stable expression of the WT1(+KTS) cDNA containing the FF-ZZ
tag. While no cell line is completely representative of any primary
cell type in vivo, the MPC-5 cell line expresses most known
podocyte cell markers and has been extensively validated in
numerous studies to provide insights into podocyte function and
glomerular disease pathogenesis [30]. The MPC-5 cells express a
temperature sensitive, interferon driven SV40 T antigen construct
that facilitates propagation at 33uC. Upon transfer to 37uC and
withdrawal of interferon, SV40 expression is turned off and
existing T antigen is inactivated whereupon the cells cease
proliferation and differentiate over 6–14 days [29].
Cell extracts were prepared from WT1(+KTS)-FF-ZZ express-
ing MPC-5 cells that were allowed to differentiate at 37uC for 14
days. Extracts were then incubated with IgG Sepharose Fastflow
beads, washed, and eluted from the column by cleavage with TEV
protease (Figure 1B) [27]. A Western blot demonstrating successful
cleavage by TEV protease is shown in Figure 1C. As a control,
RNA was prepared from the input extracts that were incubated
without IgG beads for the same amount of time as the
experimental samples that were bound to the IgG beads. Biotin-
labelled cRNAs for microarray analysis were prepared from the
input and eluate samples and microarray analysis was conducted
using Illumina Sentrix 6 mouse Beadchips (Figure 1D).
Identification of reproducibly enriched mRNA transcripts
in pulldowns from MPC-5 cell extracts
To achieve a statistically robust dataset, four independent RNP
pulldowns with the IgG beads were completed. Subsequently, four
independent pairwise comparisons between these RNP pulldowns
and the input samples processed in parallel with each experimental
Co-Purified mRNAs in Podocytes
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the expression filter, we used a 15% False Discovery Rate (FDR)
cutoff and an average 2-fold enrichment cutoff. Using the 15%
FDR cutoff, this analysis yielded a list of 88 probesets
corresponding to enrichment of 60 unique genes (Table 1, Table
S1). Notably, a number of mRNAs displayed a significantly
increased fold-enrichment compared to the input samples.
Quantitative real-time RT-PCR (qRT-PCR) was used to
independently validate enrichment of 12 of the enriched mRNAs
with variable levels of enrichment in the microarray results. For this
validation two independent pulldowns were performed using fully
differentiated WT1(+KTS) expressing MPC-5 cells. Analysis was
completed for each mRNA in the pulldown as compared to the
levels in control total input extracts. Enrichment of 11 of the 12
Figure 1. Schematic of RIP-CHIP approach used to identify functionally relevant mRNAs. (A) Diagram of the cDNA expression vector
containing two FLAG tags (‘‘FF’’) and two copies of the IgG binding domain of protein A (‘‘ZZ’’). The tobacco etch virus (TEV) protease cleavage site
is indicated, including an arrowhead to designate cleavage between glutamine and glycine residues. CMV, cytomegalovirus promoter; NeoR,
neomycin resistance cassette; pA, polyadenylation site. (B) Schematic of purification strategy using TEV protease cleavage. ZZ-tagged protein is
bound to IgG beads, washed, and the protein, along with co-purified mRNAs, are eluted from the beads by TEV protease cleavage. (C)
Demonstration of WT1(+KTS)-FF-ZZ expression in differentiated MPC-5 cells (‘‘Input’’) and the elution of WT1(+KTS)-FF bound to the beads after 3
washes and TEV protease cleavage as determined by immunoblotting with anti-FLAG antibodies. (D) Flowchart summarizing the RIP-CHIP
approach.
doi:10.1371/journal.pone.0006491.g001
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Rank Fold Enrichment Symbol Gene Name
1,10 14.2 Myh10 Non-muscle myosin IIb
2,11 12.9 Flnb Filamin B
3,50 12.55 Dbn1 Drebrin
4,9,28,86 12.4 Svil Supervillin
5,40 11.14 Ppp1r9a Neurabin I
6,13,36 10.61 Spnb2 Spectrin b2
7,50 10.33 Utrn Utrophin
8,19 10.06 Plec1 Plectin
12,65 9.14 2900026A02Rik Riken cDNA 2900026A02 gene
14 8.04 Cgn Cingulin
15,16 7.42 Lima1 Eplin/Lim domain and actin binding 1
17 6.44 St5 Supp. of tumorigenicity 5
18,37 6.24 Cgnl1 Cingulin-like
20 6.05 Aim1 Absent in Melanoma 1
21 5.79 Flna Filamin A
22 5.54 Myo6 Myosin VI
23,24,29 5.46 Actn4 a-Actinin-4
25 4.89 Nes Nestin
26,31 4.86 Iqgap1 IG motif GTPase activating protein
27 4.85 Fbxo34 F-box only protein 34
30 4.27 Specc1 Sperm antigen with calponin homology and coiled-coil domains 1
32 4 C430004E15Rik Riken cDNA C430004E15 gene
33 3.87 Mical3 Microtubule associated monoxygenase, calponin and LIM domain 3
34,39 3.85 Spna2 Spectrin a2/a-Fodrin
35,46,47,55 3.8 Dst Dystonin
38 3.71 Myo1e Myosin 1e
41,83 3.63 Actn1 a-Actinin-1
42 3.54 Myo18a Myosin XVIIIa
43 3.33 Flnc Filamin C
44 3.29 Myh9 Non-muscle myosin IIa
45 3.27 Eppk1 Epiplakin
48 2.93 Dmn Desmuslin
49,59 2.83 Lmo7 Lim domain only 7
51,57 2.7 Myo5a Myosin heavy chain 12
52 2.64 Ppp1r9b Neurabin II/Spinophilin
53 2.64 Fbxo46 F-box only 46
54 2.63 cep350 Centrosome associated protein 350
58 2.53 Pls3 T-Plastin/T-Fimbrin
60,70 2.5 Smtn Smoothelin
61 2.45 Zfp185 Zinc finger protein 185
62 2.42 Myo1b Myosin Ib
63,66 2.4 Gas2l3 Growth arrest specific 2-like 3
64 2.37 Crocc Rootletin
67 2.29 Shrm Shroom
68 2.29 Incenp Inner centromere protein
69,75 2.27 Baz1a Bromodomain adjacent to zinc finger domain 1A
71 2.22 Myo1d Myosin 1d
72 2.22 Supt6h Suppressor of Ty 6 homolog
73 2.21 2610015P09Rik Riken cDNA 2610015P09 gene
74 2.2 Gsn Gelsolin
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approximately similar to that observed using microarrays (Figure 2).
Notably, the one transcript for which qRT-PCR did not
demonstrate enrichment in the pulldown, Tmod3, represented the
least enriched gene transcript for which a probeset on the
microarray showed at least a two-fold enrichment. Thus, taken
together, the qRT-PCR data suggested that the enrichment of the
transcripts identified by microarray analysis was reproducible.
Notably, among the genes with the highest level of fold-enrichment
we frequently observed more than one probeset corresponding to
the same transcript, thereby providing additional evidence of the
validity and reproducibility of the microarray results.
Rank Fold Enrichment Symbol Gene Name
77 2.2 Dnmt1 DNA methyltransferase 1
78 2.18 Ppp1r8 Protein phosphatase 1 regulatory inhibitor subunit 8
79 2.17 Cspp1 Centrosome and spindle pole associated protein
80 2.14 Crybb3 Crystallin B3
81 2.14 Zc3h13 Zinc finger CCCH-type containing 13
82 2.14 Pprc1 Peroxisome proliferator-activated receptor gamma, coactivator-related 1
84 2.05 Arhgap23 Rho GTPase activating protein
85 2.03 Ogdh Oxoglutarate dehydrogenase (lipoamide)
87 2.03 Mcm7 Minichromosome maintenance deficient
88 2.01 Tmod3 Tropomodulin 3
List of genes that passed the 15% FDR cutoff and were more than two-fold enriched. The rank column also lists genes with multiple corresponding probesets. For genes
with multiple probesets in the list, the fold change for the highest ranked probeset is shown. For the complete list of all genes with the corresponding fold changes see
Table S1.
doi:10.1371/journal.pone.0006491.t001
Table 1. Cont.
Figure 2. Enriched mRNAs identified by microarray analysis are independently validated by qRT-PCR. Quantitative RT-PCR analysis of a
subset of the enriched mRNAs identified in this study. Two independent pulldowns using MPC-5 cell extracts stably WT1(+KTS)-FF-ZZ were
completed and total RNAs from input extracts and WT1(+KTS) enriched fractions following TEV protease cleavage were compared. Mean expression
values from triplicate assays6SD are shown relative to the input control samples.
doi:10.1371/journal.pone.0006491.g002
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enriched for those that encode components of the actin
cytoskeleton
To characterize the functions and interactions of the proteins
encoded by mRNAs from this list, the top 60 genes which passed
the 15% FDR cut-off and were more than 2-fold enriched were
compared to the background set of the all genes in the mouse
genome using Gene Ontogeny (GO) analysis through the DAVID
Bioinformatics Database (Table 2) [31,32]. Most notable was a
clearly defined enrichment in proteins encoded by these transcripts
that were components of the cytoskeleton (60.0%; p-value:
2.0610
229), were involved in cytoskeletal organization (34.5%;
p-value: 2.2610
216), and were actin binding (45.5%; p-value:
4.7610
231).
This analysis, together with the readily apparent number of
actin binding proteins among the list prompted further
investigation into the shared domains and potential interactions
among the proteins encoded by the enriched mRNAs. The most
common protein domains are liste di nT a b l e3 .W en o t e dt h a tt h e
most enriched motif among these proteins (present in 17 proteins)
was the actin-binding calponin homology (CH) domain. In 10 of
these proteins, this was the actinin-type subtype of CH domain.
Given the number of myosin proteins, there was also an expected
enrichment for domains common to the myosin family of
proteins, including the IQ calmodulin-binding motif and myosin
head and tail domains. In addition to the alpha-actinins and
myosins, there are several other examples in which more than
one member of a family of proteins was present in the list, or in
which homologous proteins were present. This included
identifying all three of the filamins (Flna, Flnb, and Flnc), non-
erythrocytic spectrins a2a n db2( S p n a 2a n dS p n b 2 ;a l s oc a l l e da
and b fodrin), cingulin and cingulin-like (Cgn and Cgnl),
neurabin I and neurabin II (Ppp1r9a and Ppp1r9b), and three
members of the plakin family of proteins: plectin, dystonin, and
epiplakin (Plec, Dst, and Eppk1). In addition to the myosins and
proteins with CH actin-binding domains, there were a number of
additional proteins on the list of proteins that are known to be
actin-binding proteins and for which a direct interaction with
actin has been shown in the published literature (Table 4). In fact,
over half of the list genes encoded actin-binding proteins (33/61)
and several more, spectrin a2 (Spna2), cingulin-like (Cgnl), and
phostensin (Kiaa1949) have been shown to co-localize with actin
and/or are implicated in actin binding. These results therefore
provided further evidence that the co-purified mRNAs encode
numerous proteins that are important components of the actin-
cytoskeleton.
Co-purified mRNAs encode proteins that are important
components of podocyte foot processes, including gene
products implicated in glomerular disease
A number of the proteins encoded by the identified mRNAs
have been directly linked to functions that are critical for the
maintenance of the structural integrity of the podocyte and in the
process of glomerular filtration. Eight of encoded proteins have
been directly shown to localize to the podocyte foot processes,
including the slit diaphragm: myosin IIa (Myh9), myosin IIb
(Myh10), drebrin (Dbn1), spectrin-a2 (Spna2), spectrin-b2
(Spnb2), a-actinin-1 (Actn1), a-actinin-4 (Actn4), and utrophin
(Utrn) [12,15,33–37]. As previously discussed, Myh9 and Actn4
encode proteins that are predominately expressed in the podocyte
within the glomerulus and have been associated with genetic forms
of glomerular disease. Interestingly, biochemical purification of
Actn4 identified Myh9 as the predominant interacting protein,
suggesting that interactions between these proteins are a part of a
protein interaction network in podocytes that underlie mainte-
nance of structural cytoskeletal integrity [38]. Notably in the list of
genes that passed the 15% FDR, three positive probesets for Actn4
were present in the top 30 ranked probesets, providing strong
evidence of reproducible enrichment.
Nephrin is one of the most important proteins for maintenance
of slit diaphragm structure and function. Numerous studies have
shown that connections between the cytoplasmic tail of nephrin to
the underlying actin cytoskeleton are critical for its function [39].
While the Nephrin mRNA was not detected in our podocyte cell
line extracts by the single probeset corresponding to it, a number
of nephrin-interacting proteins were identified in this study. For
example, it has been suggested that IQGAP1, SPNA2, SPNB2,
and actinin proteins form a ‘‘nephrin multiprotein complex’’
Table 2. Gene Ontogeny (GO) Analysis.
Category GO term #Of Genes (%) p-value Benjamini-Hochberg
Molecular Function Actin binding 25 (45.5) 4.7610
231 1.3610
227
Cytoskeletal protein binding 27 (49.1) 1.4610
230 1.8610
227
Calmodulin binding 10 (18.2) 2.3610
211 2.1610
28
Motor Activity 10 (18.2) 3.9610
210 2.7610
27
Cellular Component Cytoskeleton 33 (60.0) 2.0610
229 1.6 610
226
Actin cytoskeleton 21 (38.2) 6.8610
226 2.7610
223
Non-membrane bound organelle 35 (63.6) 4.4610
225 1.1610
222
Cytoskeletal part 20 (36.4) 4.8610
216 7.0610
214
Myosin complex 10 (18.2) 1.1610
213 1.4610
211
Biological Processes Cytoskeletal organization 19 (34.5) 2.2610
216 1.2610
212
Actin filament-based process 14 (25.5) 2.8610
215 7.2610
212
Actin cytoskeleton organization 12 (21.8) 1.8610
212 3.1610
29
List of the most statistically significant GO terms resulting from analysis between enriched genes and the entire mouse genome background set. The number and
percentage of genes in each category are provided. The p-value (EASE score) indicates the probability that these genes are enriched in these categories due to random
chance. The Benjamini-Hochberg score globally corrects enrichment p-values to account for multiple testing.
doi:10.1371/journal.pone.0006491.t002
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linking nephrin to the actin cytoskeleton [35,40]. Interestingly,
IQGAP1, an important cytoskeletal adhesion protein, not only
colocalizes with Nephrin but also has been shown to interact with
Phospholipase C epsilon (PLCE1). PLCE1 mutations have been
shown to result in familial nephrotic syndrome suggesting that
such interactions may be crucial in cell adhesion and reorgani-
zation as well as maintaining the structural integrity of the actin
cytoskeleton [34].
As has been shown for ACTN4, mutations in TRPC6 are also
associated with familial FSGS. TRPC6 has also been localized to
the slit diaphragm and a recent study identified proteins associated
with TRPC5 and TRPC6 [41]. Using antibodies for TRPC5, this
study listed 15 unique cytoskeletal proteins of which 11 were
encoded by our target mRNAs: Spna2, Spnb2, Myh9, Myh10,
Myo5a, Myo6, Actn1, Actn4, Dbn1, Pppar9a, and Ppp1r9b.
While not all of these proteins were specifically shown to be
TRPC6 binding proteins in this publication, one of the authors
reports that at least eight, Spna2, Spnb2, Myh9, Myh10, Actn1,
Acnt4, Dbn1, Gsn, do also specifically co-IP with TRPC6 (W.P.
Schilling, personal communication). It has been suggested that
TRPC6 functions at the slit diaphragm to transmit Ca flux into
signaling pathways that are involved in reorganization of the actin
cytoskeleton [42,43]. Thus, these proteins that associate in
complexes with TRPC6 may likewise comprise important
components of the foot process cytoskeleton.
Abnormal expression levels of several of the enriched mRNAs have
also been observed in various renal disease models. In a mouse model
of HIV associated nephropathy (HIVAN), a reduction in the
expression of filamin A (Flna) was seen in podocytes [44]. The
authors suggested that reduced filamin expression was likely one factor
that led to cytoskeletal abnormalities, or ‘‘softness’’ in HIVAN
podocytes compared to wild-type podocytes. The mRNAs for Flna,
Flnb,a n dFlnc were all enriched in our study, indicating that
maintenance oftheirexpressionin response to stress thus might beone
potential functional role of this isoform. By contrast, another of our
highly enriched mRNAs, that encoding myosin IIb (Myh10)h a sb e e n
shown to be overexpressed in a number of glomerular disease models
(e.g. [45]). Thus, collectively, review of the literature reveals that a
number of the proteins encoded by the mRNAs we identified are
implicated in critical functions of the podocyte and thus, by extension,
may potentially be involved in glomerular pathogenesis as well.
Enrichment of co-purified mRNAs was not WT1(+KTS)
dependent
To date a-actinin-1 (Actn1) is the only identified cellular mRNA
shown to be bound by WT1(+KTS) [46]. Two positive probesets
for Actn1 were present in the top 88 ranked probesets. This
observation was consistent with the hypothesis that the mRNAs
that we identified were bound by and associated specifically with
WT1(+KTS). However, we were surprised to find that in
subsequent validations, we detemined that the enrichment these
mRNAs was clearly not due to association with WT1(+KTS).
Further validation experiments using qRT-PCR were carried out
to more definitively determine whether the enrichment of these
mRNAs was specifically due to association with WT1(+KTS).
Additional pulldowns were performed, using cell extracts from
MPC-5 cells stably expressing WT1(+KTS)-FF-ZZ, but also using
control cell extracts from MPC-5 cells expressing the empty vector
plasmid. Because of the significant enrichment of Myh10, we used
qRT-PCR analysis of Myh10 transcripts for these validation steps.
To our initial surprise, we noted a significant enrichment of Myh10
mRNA in the eluates of both the experimental (Figure 3A) and
Table 3. Protein domains enriched in products of identified mRNAs.
Common Domains Proteins Encoded by Enriched mRNAs
Calponin homology domain Flnb, Spnb2, Utrn, Plec1, Flna, Actn4, Iqgap1, Mical3, Specc1, Dst, Actn1, Flnc, Pls3, Lmo7, Smtn, Gas2l3, Mical3
Actin-binding, actinin-type Flnb, Spnb2, Utrn, Plec1, Flna, Actn4, Dst, Actn1, Flnc, Pls3
Tropomyosin Myh10, Ppp1r9a, Cgn, Cgnl, Specc1, Myo18a, Myh9, Myo1b, Crocc, Incenp, Ppp1r9b
IQ calmodulin-binding motif Myh10, Myo6, Iqgap1, Myo18a, Myh9, Myo1b, Myo1e, Myo5a, Myo1d
Spectrin repeat Spnb2, Utrn, Plec1, Actn4, Spna2, Dst, Actn1
ATP/GTP-binding site motif A (P-loop) Myh10, Myo6, Dst, Myh9, Myo1b, Gas2l3
Myosin tail Myh10, Cgn, Cgnl, Myh9, Myo1b, Myo1e, Myo1d
Myosin head Myh10, Myo6, Myo18a, Myh9, Myo1b, Myo1e, Myo5a, Myo1d
Calcium binding EF Hand Actn4, Spna2, Dst, Actn1, Pls3
Proline-rich region Dbn1, C430004e15Rik, BC030863, Smtn, 2310014H01Rik, Shrm
LIM zinc-binding domain Lima1, Mical3, Lmo7, Mical3, Zfp185
PDZ domain Ppp1r9a, Myo18a, Lmo7, Ppp1r9b, Shrm
Filamin/ABP280 repeat Flnb, Flna, Flnc
Prefoldin Cgnl, Specc1, Crocc
Ig-like fold Flnb, Flnc
WW/Rsp5/WWP Utrn, Iqgap1
Beta and Gamma crystalline Aim1, Crybb3
GAS2 domain Dst, Gas2l3
Pleckstrin-like Spnb2, Arghap23
Plectin repeat Plec1, Dst, Eppk1
SH3 domain Spna2, Dst, Myo1e
doi:10.1371/journal.pone.0006491.t003
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and thus the enrichment of Myh10 in the pulldowns using empty
vector control extracts clearly indicated that the enrichment of this
mRNA did not require an association with WT1(+KTS).
WT1(+KTS) independent enrichment of a number of the other
candidate mRNAs was also confirmed by qRT-PCR in the empty
vector pulldowns, including Dbn1 (data not shown). Thus, despite
the identification of a previously described WT1(+KTS) target
mRNA in the results and the remarkable physiologically relevant
functions of the encoded proteins, these results established that their
identification was not due to WT1(+KTS) binding as envisioned by
the experimental design.
Protein components of the actin cytoskeleton were co-
purified with the enriched mRNAs
Although the co-purified mRNAs were not enriched due to an
association with WT1(+KTS), the significant examples of their
common functions in the actin cytoskeleton raised the question as
to how or why they were specifically enriched in the pull down
assays. Given the functional interrelationships among the set of
identified transcripts, we therefore sought to determine the basis
on which purification approach unveiled this subset of enriched
mRNAs.
We initially hypothesized that the common enrichment of these
mRNAs was due to an association with other RBPs, protein
complexes, or a soluble protein fraction in the purified eluate
samples. Therefore mass spectrometry was used to identify
proteins in the purified eluates following TEV protease cleavage.
It should be noted that this analysis was completed from bands
that were excised from the WT1(+KTS) gel pictured in Figure 4A.
This analysis revealed a predominant presence of actin, tubulin,
and elongation factor 1a (EF1a) in the purified eluates. Alpha and
gamma subunits of actin were identified corresponding to a total of
98 peptide matches of the protein sequence, beta and alpha
Table 4. Enriched mRNAs that encode proteins with well established and/or have been shown to bind directly to actin.
Gene Symbol Actin Binding domain Reference
Myh10 Myosin head
Flnb Alponin homology domain/actinin-type actin-binding domain
Dbn1 Cofilin/tropomyosin type actin-binding domain [72]
Svil Gelsolin homology domain [73]
Ppp1r9a neural F-actin binding protein [74,75]
Spnb2 Calponin homology domain/actinin-type actin-binding domain
Utrn Calponin homology domain/actinin-type actin-binding domain [76,77]
Plec1 Calponin homology domain/actinin-type actin-binding domain [78]
Cgn [79]
Lima1 [80]
Flna Calponin homology domain/actinin-type actin-binding domain
Myo6 Myosin head
Actn4 Calponin homology domain/actinin-type actin-binding domain
Iqgap1 Calponin homology domain [81]
Specc1 Calponin homology domain
Mical3 Calponin homology domain
Dst Calponin homology domain/actinin-type actin-binding domain
Myo1e Myosin head
Actn1 Calponin homology domain/actinin-type actin-binding domain
Myo18a Myosin head [82]
Flnc Calponin homology domain/actinin-type actin-binding domain
Myh9 Myosin head
Ppp1r9b [83,84]
Pls3 Calponin homology domain/actinin-type actin-binding domain [85]
Lmo7 Calponin homology domain [86]
Myo5a Myosin head
Smtn Calponin homology domain [87]
Myo1b Myosin head
Gas2l3 Calponin homology domain [88]
Shrm APX/Shrm domain 1 [89]
Myo1d Myosin head
Gsn Gelsolin homology domain
Tmod3 [90]
doi:10.1371/journal.pone.0006491.t004
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PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e6491Figure 3. The enrichment of the mRNAs in the pulldown assays does not require association with WT1(+KTS). (A) Elution of Myh10
mRNA from WT1(+KTS)-FF-ZZ containing IgG beads occurs with addition of bovine serum albumen (BSA) as well as TEV protease. Shown is qRT-PCR
analysis of Myh10 and Gapdh in IP’s using cell extracts from MPC-5 cells stably expressing WT1(+KTS)-FF-ZZ. Mean expression values from triplicate
assays6SD are shown relative to Input samples. (B) The same enrichment of Myh10 mRNA shown in (A) in response to TEV protease and BSA using
extracts from cells expressing the pIN empty vector. Mean expression values from triplicate assays6SD are shown relative to Input samples. (C)
Immunoblot demonstrating that WT1(+KTS)-FF-ZZ elution occurs only upon addition of TEV protease and not with addition of BSA or TEV cleavage
buffer alone. Presence of the FLAG tagged WT1(+KTS) protein was determined using anti-FLAG antibodies.
doi:10.1371/journal.pone.0006491.g003
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peptide matches of the protein sequence, and EF1a was identified
corresponding to 52 peptide matches of the protein sequence.
The presence of actin and tubulin in the eluate fractions,
suggested that a fraction containing cytoskeletal structural proteins
may in part have accounted for our findings. However, it was not
clear how these proteins might have been eluted following TEV
protease cleavage given the specificity of this protease. We thus
investigated whether the cleavage step of the ‘ZZ-tag’ by the TEV
protease was in fact required for enrichment of these proteins and
mRNAs. In order to investigate the role of the TEV protease,
three separate pulldowns were completed using cell extracts from
MPC-5 cells stably expressing WT1(+KTS). As an additional
control, cell extracts from cells stably expressing the empty
expression vector were used. In these pulldowns, MPC-5 cell
extracts were incubated with IgG Sepharose Fastflow beads,
washed, and eluted either by adding TEV protease to the column
to promote cleavage of the ZZ-tag, an equal amount of BSA in
place of TEV protease, or buffer alone to the column. Coomassie
staining comparing each of these eluates revealed that, other than
the bands corresponding to TEV protease or BSA bands, the
eluates in all three cases revealed essentially the same set of protein
bands (Figure 4A). Furthermore, the same bands were also seen in
eluates from the empty vector control extracts. These bands
represent those submitted for mass spectrometry analysis and
therefore their presence in the eluates was not only independent of
WT1(+KTS), but also did not specifically require elution with
TEV protease (Figure 4A). The presence of b-actin and EF1a were
also confirmed by Western blotting (Figure 4B and C). qRT-PCR
analysis of these pulldowns also demonstrated that enrichment of
Myh10 mRNA was similarly observed in eluate samples using TEV
protease or the BSA (Figure 3A and B). Additional Western blots
confirmed that FLAG-tagged WT1 was still present in the TEV
protease eluates following cleavage by TEV protease but, as
expected, was not present in control pulldowns using BSA or
buffer alone, providing definitive evidence that WT1 was not
required for mRNA enrichment (Figure 3C).
Collectively, these data demonstrate that TEV protease
cleavage and the presence of WT1(+KTS) was not required for
identification of these mRNAs. The most straightforward technical
detail to account for the presence of these proteins and mRNAs is
based on the method by which washes and the elutions were
carried out by spin column chromatography. The flow through
and wash fractions were harvested by pelleting of the beads by
Figure 4. Protein components of the actin cytoskeleton are present in eluates used to identify the enriched subset of mRNAs. (A)
Coomassie stained gels demonstrating proteins present in the IP eluates using MPC-5 cell extracts stably expressing WT1(+KTS)-FF-ZZ or empty
vector expression constructs. Arrows correspond to the bands from TEV eluate lane of the WT1(+KTS)-FF-ZZ gel that were excised and submitted for
mass spectrometry analysis. The same arrows also indicate the bands which correspond to tubulin and elongation factor 1a (top arrow) and actin
(bottom arrow). * indicates TEV protease and ** indicates BSA bands. The actin (B) and elongation factor 1a (C) proteins are not enriched in the
eluates from IgG beads. Immunoblots confirming the presence, but lack of enrichment of b-actin and elongation factor 1a in eluate samples from
WT1(+KTS)-FF-ZZ and empty vector control pulldowns with anti-b-actin and anti-elongation factor 1a antibodies.
doi:10.1371/journal.pone.0006491.g004
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While the final wash fractions were reproducibly clear of
significant amounts of protein, the subsequent elutions were then
performed using microbiospin columns. At this step then, the
beads were trapped in the column and the eluates harvested from
the material that was centrifuged through the filter contained
residual protein material that previously was trapped with the
beads. This data suggests that in these experiments the actin,
tubulin, and EF1a were trapped by the IgG Sepharose Fastflow
beads at each wash step and during the final elution, a semi-
soluble fraction was forced through the column. Importantly,
Western blots comparing input and purified eluate samples
probing for Myh10, Dbn1, and IQGAP1 demonstrated little or
no protein present in the purified eluate samples, compared to
strong signals in the input samples (data not shown). This suggests
that identification of these transcripts did not result from trapping
of the cytoskeletal proteins that were encoded by the respective
mRNAs. Rather, the protein fraction obtained likely represented a
cytoplasmic complex of proteins in which the mRNAs identified
by microarray analysis were associated and subsequently enriched
relative to the input fractions.
In an attempt to further account for the co-enrichment of these
mRNAs we also used a number of bioinformatics algorithms to
investigate whether a common sequence motif could be identified
in these transcripts. This analysis included the 39 untranslated
regions (UTRs) as well a 59 UTRs and coding sequences.
However, we were unable to identify a sequence motif that was
common to most of these mRNAs and we did not identify
significant enrichment for the binding sites of known RNA binding
proteins (data not shown). These findings thus cannot establish
whether these co-regulated mRNAs are bound by a single trans-
acting factor, but suggest that more than one RNA binding protein
is involved in their regulation. However, we suspect that the co-
enrichment of these mRNAs in the purifications itself was not
dependent upon direct binding to one or more of these trans-
factors.
Discussion
The structural and functional integrity of the podocyte is
essential for the maintenance of the glomerular filtration barrier
and components of the actin cytoskeleton have been shown to be
crucial for podocyte function and response to stress and injury.
However, it has also been noted that the podocyte cytoskeleton
remains to be fully defined and thus it is likely that numerous
undiscovered components are also important for podocyte
function [44]. While our experiments were designed to uncover
WT1(+KTS) associated mRNAs, we nonetheless identified
through serendipity a subset of mRNA transcripts that encode
for proteins that exhibit a remarkable degree of interactions with
one another as components of the actin cytoskeleton. Extensive
literature reveals that there are numerous instances in which these
encoded proteins have been shown to interact with one another
and/or to be present in common protein complexes in podocytes
or other polarized cell types. Considering the collective set of
interactions among these proteins and other well characterized
podocyte proteins, a putative cytoskeletal ‘‘interactome’’ compris-
ing these proteins can be envisioned (Figure 5). The protein
interactions shown in this diagram represent known interactions
that constitute important components of the actin cytoskeleton.
Figure 5. Schematic representation of a hypothesized podocyte protein ‘‘interactome’’ encoded by enriched mRNAs. Large black
type indicates proteins encoded by mRNAs identified in this study. Smaller grey type is used to indicate several known podocyte foot process
proteins in order to orient the figure. The interactions shown represent published results showing either direct interactions or presence in common
protein complexes.
doi:10.1371/journal.pone.0006491.g005
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that were identified in our analysis may also be shown to
contribute important functions to this interactome. Thus, together,
the collective links between these proteins suggests that they
contribute to the structure and function of podocytes and to the
reorganization of the cytoskeleton that occurs in response to the
normal stresses involved in sustaining filtration function as well as
in response to injury. Importantly, the genes that encode several of
these mRNAs (e.g. Actn4, Myh9) have previously been implicated in
genetic forms of kidney disease or the encoded proteins have been
shown to interact with gene products that have been shown to play
a role in glomerular disease. Consequently, given these direct and
indirect links between the proteins and genetic glomerular
diseases, we suggest that the genes we identified might be
considered candidate genes whose mutation may also lead to
glomerular disease due to podocyte pathophysiology. Further-
more, the proteins, pathways and structural interactions that are
defined by these mRNAs may also be involved in the
pathophysiology of secondary causes of the nephritic syndrome
that may interfere with their function through alternative
mechanisms. In sum, we hypothesize that the proteins encoded
by these mRNAs include a number of previously uncharacterized
podocyte proteins that might play essential roles in maintaining
the morphology and function of this highly specialized cell type. It
is hoped that the importance of the defined proteins, including
previously uncharacterized proteins, and their interactions in the
podocyte will be better clarified through future cellular and
molecular investigations.
The proteins encoded by these mRNAs may not only play an
important role in maintaining the structure of the podocyte actin
cytoskeleton,butalso function inregulatingtheactin cytoskeletonin
other polarized cell types. Structural and functional parallels have
been drawn between the podocyte slit diaphragm and other sites of
cell-cell contact, including adherens junctions and post-synaptic
dendritic spines [47–50]. A number of important analogies between
podocytes and neurons suggest that they have several common
structural and functional features [47]. For example, both have a
well developed and dense actin cytoskeleton and cellular processes.
An important cytoskeletal component of podocytes, synaptopodin,
has also been shown to have important functions in synaptic
transmission at dendritic spines and another important dendritic
spine component, dendrin, was recently shown to also be a
component of the slit diaphragm [47,51]. The submembranous
region of both dendritic spines and slit diaphragms consists of
detergent insoluble protein complexes that are believed to be
organizers of signaling complexes. In the podocyte (and other cell
types) these have been referred to as ‘‘lipid rafts,’’ whereas a well
studied analogous structure at the dendritic spines is termed the
post-synaptic density (PSD) [50]. Interestingly, several of the
proteins encoded by these mRNAs are dendritic spine proteins
that have been extensively characterized to have essential functions
duringsynaptic development and function. In all, 15 of the enriched
mRNAs have been shown by several studies to be components of
dendritic spines generally, or specifically in the post-synaptic
densities (PSD): MYH10, DBN1, IQGAP1, PPP1R9A, PPP1R9B,
SPNB2, MYO6, ACTN4, ACTN1, MYH9, MYO18A, MYO1B,
MYO5A, GSN, and PLEC1 [52]. Additionally, the podocyte foot
processes have important parallels with other dynamic actin-based
cellular projections such as lamellipodia, filopodia, podosomes, and
pseudopodia [42,53]. A number of the proteins encoded by these
mRNAs have been shown to be components of or participate in
formation of these cellular compartments: MYO6, IQGAP1, T-
plastin, MYH9, actinin, filamin, MYO18A, drebrin, and MYO1B
[36,54–57]. Thus, it may prove the case that some of the other less
characterized proteins encoded by the co-purified mRNAs will also
be found to be important components of microfilament networks in
these subcellular structures and processes.
The unexpected finding that the identified transcripts were not
associated with WT1(+KTS) prompted us to attempt to uncover a
plausible explanation to account for the identification of this subset
of mRNAs encoding a remarkable functionally interrelated set of
proteins. The identification of actin and EF1a in the co-eluted
fractions provides some insight into the means by which these
mRNAs were enriched and may further provide mechanistic
insights into the cell biological implications of their co-enrichment.
Most simply, it appears that semi-soluble cytoskeletal protein
complexes were trapped on the beads during washes, but eluted
when this material was more forcefully separated from the beads
using a spin column. This possibility would be consistent with a
previous study showing that components of the actin cytoskeleton,
including actinins and filamins can be physically entrapped on
magnetic microbeads [58]. However, one explanation that might
then be suggested is that the mRNAs we identified were all co-
purified in association with the encoded proteins. However, this
not likely the case as Western blots comparing input and purified
eluate samples probing for Myh10, Dbn1, and Iqgap1 resulted in
strong signals for these proteins in the respective input samples. By
contrast, there was little or no detectable level of these proteins
eluate samples (data not shown). Since only the mRNAs and not
the corresponding proteins were enriched in the purified eluate
samples, these results suggest that our mRNAs were not merely
identified by means of trapping or pulling down protein
components of the cytoskeleton. Although it is possible that the
co-purification of these mRNAs may have occurred due to
unanticipated binding of a different RNA binding protein to the
column, we find this less likely. Our mass spectrometry data are
not consistent with this possibility and the lack of a common
binding motif among these transcripts suggests they are bound by
more than a single RNA binding protein.
The presence of EF1a might provide additional insight into how
these mRNAs may have been identified and suggest the interesting
hypothesis that they share a common subcellular localization and
undergo localized translation. EF1a has been shown to associate
with the cytoskeleton through actin binding sites. It has further
been proposed that EF1a associated with a subpopulation of actin
filaments to which mRNA is localized [59]. The same authors
further proposed that EF1a may bind localized mRNAs to actin
filaments at sites where they are anchored. It is worth noting in the
context of analogies between the podocyte slit diaphragm and
neuronal dendrites that numerous mRNAs that encode dendritic
proteins are themselves localized to dendritic spines where they
appear to be dynamically translated at their sites of expression [60]
Just as a number of the proteins encoded by these mRNA are
localized to dendrites, it is also noteworthy that 15 of the enriched
mRNAs themselves have been shown to localize to dendritic
spines, the post-synaptic density, or (in one case) at the post-
synaptic membrane of the neuromuscular junction: Ppp1r9b, Dbn1,
Myh9, Plec1, Spna2, Spnb2, Actn4, Actn1, Gsn, Nes, Pls3, Utrn, Dst,
Myo1b, Shrm [61–69]. Since 7 of these proteins (as well as Myh10)
have been shown to be localized to podocyte foot processes, these
collective observations raise an interesting speculation that a
number of the RNA transcripts we identified may similarly be
localized at the slit diaphragm. It might be the case that these
transcripts undergo dynamic translation at sites of expression in
foot processes in response to extracellular cues and signaling
pathways. However, while this is an intriguing possibility, further
more complex cell biological studies would clearly be needed to
provide direct evidence of this hypothesis.
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identification of a putative protein interaction network, we were
unfortunately unable to provide further insight into the hypoth-
esized roles of WT1(+KTS) as an RNA binding protein. While we
were unable to identify true WT1-associated mRNAs in this work,
a number of technical factors may have interfered with the
identification of such mRNAs. For example, the significant
enrichment of mRNAs that were present in the semi-soluble
protein fractions that we isolated may have masked the
identification of such transcripts. Thus, further studies are needed
to further investigate the proposed post-transcriptional functions of
WT1 in podocytes as well as other cell types in which it is
expressed.
In conclusion, while the findings we obtained were not
successful in identifying novel WT1(+KTS) RNA targets, the
mRNAs identified through microarray analysis revealed a
surprising set of gene products with remarkably interrelated
functions in maintenance of the actin cytoskeleton, including
several with known important roles in podocytes as well as
neuronal dendrites. Further investigation of several of the less well
characterized proteins encoded by these mRNAs may uncover
previously unknown components and pathways that are essential
for the function of these specialized cell types.
Materials and Methods
Plasmids
The expression vector used to facilitate production of C-
terminal FF-ZZ tagged WT1(+KTS) in stably transfected MPC-5
mouse podocyte cells has previously been described in detail [27].
Cell Culture
MPC-5 cells were propagated at 33
uC in RPMI 1640 with
25 mM HEPES cell culture medium (Gibco) supplemented with
10% fetal bovine serum, 10 U/ml interferon gamma (Boehringer),
100 units/ml penicillin, 100 mg/ml streptomycin, 10 mg/ml
insulin-transferrin-sodium selenite (Roche). The MPC-5 cells were
allowed to differentiate by withdrawal of interferon gamma from
the culture medium and transferred from 33
uCt o3 7
uC for 14 days
[29]. Cells were transfected using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions and stable selection
was carried out using 0.5 mg/ml of G418 (Gibco).
Preparation of cell extracts and quantification of protein
content
MPC-5 cell extracts were prepared as previously described in
[27]. The total amount of protein in extract preparations was
quantified using the Bradford protein assay (Bio-Rad). All extracts
were prepared from differentiated MPC-5 cells.
Ribonucleoprotein immunoprecipitation (RNP-IP) and
RNA precipitation
Immunoprecipitation using IgG resin (Amersham) binding to
the ZZ epitope tag of recombinant WT1 protein has previously
been described, with the exception that RNase A was not added
with the third wash in step 23 ([27]; steps 18 through 28). After
TEV protease-cleavage and elution from the IgG beads, the eluted
ribonucleoprotein fraction was directly subjected to RNA
precipitation using TRIzol reagent (Invitrogen) per manufacturer’s
instructions. This RNA precipitation was carried out concomi-
tantly with that of the respective input sample. RNA samples were
quantified and confirmed for purity using the NanoDrop
spectrophotometer and Agilent Bioanalyzer, respectively.
mRNA amplification, labeling, and hybridization to
Illumina mouse Sentrix-6 microarrays
650 ng of purified total RNA from four replicates each of input
control extract or immunoprecipitated sample were single-round
amplified and biotin-labeled using the Ambion Message-Amp II-
Biotin Enhanced RNA amplification kit (Applied Biosystems)
according to manufacturer’s instructions. Amplified cRNA
samples were quantified and confirmed for purity using the
NanoDrop spectrophotometer and Agilent Bioanalyzer, respec-
tively. After fragmentation, the biotin-labeled antisense cRNAs
were hybridized to Illumina Sentrix-6 Mouse Expression Beadchip
(Illumina) containing 46,657 probe sets. Raw data from the
microarray analysis has been deposited in the Gene Expression
Omnibus (GEO) database at the National Center for Biotechnol-
ogy Information (NCBI) website under accession code GSE16942.
Microarray Analysis
The results were first filtered for probesets that were detected
above an expression threshold (‘‘MPC-5 transcriptome’’). Spotfire
9.0 was used to select probesets among the experimental
hybridization samples with a detection value of$0.95 (p-value
0.05) in at least three of the four experimental replicates. Of the
46,657 probesets on the CHIP, 15,094 probesets passed this
detectable expression filter, which roughly corresponded to a
signal intensity of approximately 100 at the lower end. After log2
transformation, a two way mixed model ANOVA across all four
pairs was used to calculate false discovery rates (FDR) using the
resulting p-values according to the Benjamini-Hochberg method
as implemented in Partek Genomics Suite v. 6.3 [70]. Using a
15% FDR cutoff we identified a total of1764 probesets that
demonstrated a difference in average expression between to
experimental and control sets (including both positive or negative
differences). The complete list of these probesets is presented in
Table S1.
Gene Ontogeny (GO) Analysis
Of the 60 genes that passed the 15% FDR and the two-fold cutoff,
55 either had pre-assigned Human Gene Nomencltaure Committee
(HCGN) approved gene symbols in the data output, or the gene
symbol could be manually assigned by searching BLAT in the UCSC
genome browser using the probe sequence. These 55 symbols were
input as a gene list into the DAVID Bioinformatics Database and
assigned DAVID ID’s. The three riken clones that passed the 15%
FDR and two-fold cutoff were excluded from this analysis. Of the
over 15,000 genes that passed the expression threshold, less than half
could be identified in the DAVID Bioinformatics Database and
assigned DAVID ID’s using the available accession numbers in the
results files. Therefore, we instead used the entire mouse genome list
in DAVID as the background set for the comparison with the 55
genes from the enriched dataset. GO analysis was completed
analyzingallmolecularfunctions,cellularcomponents,andbiological
processes [31,32].
Antibodies and Immunoblotting
Immunoblotting was performed as described in [71]. Antibodies
used were anti-flag M2 mouse monoclonal antibody (Sigma;
1:1,000 dilution), Anti-anti-b-actin clone AC-15 (Sigma; 1:1000
dilution), anti-elongation factor tu clone sc-21758 (Santa Cruz;
1:50 dilution).
Real-time qRT-PCR
One microgram of total RNA was used to generate cDNA with the
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems).
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Assays for Myh10 (Assay ID: Mm00805131_m1), Flnb (Assay ID:
Mm01311723_m1), Dbn1 (Assay ID: Mm00517314_m1), Svil (Assay
ID: Mm01233200_m1), Spnb2 (Assay ID: Mm00486365_m1), Actn4
(Assay ID: Mm00502489_m1), Nes (Assay ID: Mm00450205_m1),
Iqgap1 (Assay ID: Mm01313746_m1), Spna2 (Assay ID:
Mm01326617_m1), Dst (Assay ID: Mm01227142_m1), Actn1
(Mm01304398_m1), Tmod3 (Assay ID: Mm00497523_m1), Gapdh
(Assay ID: Mm99999915_g1) normalized to Ubiquitin C (Assay ID:
Mm01201237_m1) (Applied Biosystems). The ddCt method of relative
quantification was used on a 7500 Fast Real-Time PCR machine with
SDS software (Applied Biosystems).
Supporting Information
Table S1 Complete list of all probesets that passed the
expression filter
Found at: doi:10.1371/journal.pone.0006491.s001 (0.29 MB
XLS)
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